首页   按字顺浏览 期刊浏览 卷期浏览 SCH 42495
SCH 42495

 

作者: &NA;,  

 

期刊: Drugs in R & D  （ADIS Available online 1999）
卷期: Volume 1, issue 4  

页码: 354-356

 

ISSN:1174-5886

 

年代: 1999

 

出版商: ADIS

 

数据来源: ADIS

 

摘要:

&NA;SCH 42495 is the orally active prodrug of the neutral endopeptidase (NEP) inhibitor SCH 42354. It is being developed as a cardiovascular agent, and is currently undergoing phase II clinical trials in Japan with Schering-Plough for the treatment of hypertension and heart failure.

 

点击下载:  PDF (27KB)



返 回